These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8625302)

  • 1. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.
    Jaworski DM; Kelly GM; Piepmeier JM; Hockfield S
    Cancer Res; 1996 May; 56(10):2293-8. PubMed ID: 8625302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain enriched hyaluronan binding (BEHAB)/brevican increases aggressiveness of CNS-1 gliomas in Lewis rats.
    Nutt CL; Zerillo CA; Kelly GM; Hockfield S
    Cancer Res; 2001 Oct; 61(19):7056-9. PubMed ID: 11585735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
    Viapiano MS; Bi WL; Piepmeier J; Hockfield S; Matthews RT
    Cancer Res; 2005 Aug; 65(15):6726-33. PubMed ID: 16061654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican.
    Jaworski DM; Kelly GM; Hockfield S
    Exp Neurol; 1999 Jun; 157(2):327-37. PubMed ID: 10364444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BEHAB/brevican: an extracellular matrix component associated with invasive glioma.
    Gary SC; Hockfield S
    Clin Neurosurg; 2000; 47():72-82. PubMed ID: 11197728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member.
    Matthews RT; Gary SC; Zerillo C; Pratta M; Solomon K; Arner EC; Hockfield S
    J Biol Chem; 2000 Jul; 275(30):22695-703. PubMed ID: 10801887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion In vivo.
    Zhang H; Kelly G; Zerillo C; Jaworski DM; Hockfield S
    J Neurosci; 1998 Apr; 18(7):2370-6. PubMed ID: 9502798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican.
    Nutt CL; Matthews RT; Hockfield S
    Neuroscientist; 2001 Apr; 7(2):113-22. PubMed ID: 11496922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
    Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
    Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma.
    Viapiano MS; Matthews RT; Hockfield S
    J Biol Chem; 2003 Aug; 278(35):33239-47. PubMed ID: 12799382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of SV40Tag, Rb and IRS-1 in glioma detected by tissue microarray and their relation with tumorigenesis and progression of gliomas].
    Qian ZY; Wu YY; Huang Q; Zhai DZ; Zhu Q; Wang AD; Huo HM; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):432-6. PubMed ID: 19024517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
    Tallen G; Riabowol K; Wolff JE
    Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L; Li Q; Wang L; Liu Z; Sun T
    Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
    Konduri SD; Osman FA; Rao CN; Srinivas H; Yanamandra N; Tasiou A; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Kouraklis G; Rao JS
    Oncogene; 2002 Jan; 21(6):921-8. PubMed ID: 11840337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
    Viapiano MS; Hockfield S; Matthews RT
    J Neurooncol; 2008 Jul; 88(3):261-72. PubMed ID: 18398576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
    Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
    Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
    Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
    Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
    Kambara H; Okano H; Chiocca EA; Saeki Y
    Cancer Res; 2005 Apr; 65(7):2832-9. PubMed ID: 15805284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.